Xiaolong Yang

Tumor suppressor LATS1 is a negative regulator of oncogene YAP.

Molecular characterization of human homologs of yeast MOB1.

Identification of LATS transcriptional targets in HeLa cells using whole human genome oligonucleotide microarray.

MicroRNA-193b represses cell proliferation and regulates cyclin D1 in melanoma.

LATS tumor suppressor: a new governor of cellular homeostasis.

Taxol resistance in breast cancer cells is mediated by the hippo pathway component TAZ and its downstream transcriptional targets Cyr61 and CTGF.

Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability [corrected].

Molecular mechanism of size control in development and human diseases.

LATS1 tumor suppressor is a novel actin-binding protein and negative regulator of actin polymerization.

miR-193b Regulates Mcl-1 in Melanoma.

Tumour suppressor genes in chemotherapeutic drug response.

Cell surface expression of human ether-a-go-go-related gene (hERG) channels is regulated by caveolin-3 protein via the ubiquitin ligase Nedd4-2.

WWP1 E3 ligase targets LATS1 for ubiquitin-mediated degradation in breast cancer cells.

BMP4 is a novel transcriptional target and mediator of mammary cell migration downstream of the Hippo pathway component TAZ.

Fer protein-tyrosine kinase promotes lung adenocarcinoma cell invasion and tumor metastasis.

YAP-induced resistance of cancer cells to antitubulin drugs is modulated by a Hippo-independent pathway.

The Hippo pathway in chemotherapeutic drug resistance.

Roles of the Hippo pathway in lung development and tumorigenesis.

Recombinant hamster oviductin is biologically active and exerts positive effects on sperm functions and sperm-oocyte binding.

Hippo Component TAZ Functions as a Co-repressor and Negatively Regulates ΔNp63 Transcription through TEA Domain (TEAD) Transcription Factor.

Regulation of sensitivity of tumor cells to antitubulin drugs by Cdk1-TAZ signalling.

WWTR1 (WW domain containing transcription regulator 1).

The roles of the Hippo pathway in cancer metastasis.

TAZ induces lung cancer stem cell properties and tumorigenesis by up-regulating ALDH1A1.

Essential signaling in loss-related tumours: the therapeutic potential of CRL4 and mTOR combined inhibition.

The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1.

Cysteine residues are essential for dimerization of Hippo pathway components YAP2L and TAZ.

Identification of Cdk1-LATS-Pin1 as a Novel Signaling Axis in Anti-tubulin Drug Response of Cancer Cells.

A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis.

PI3K Positively Regulates YAP and TAZ in Mammary Tumorigenesis Through Multiple Signaling Pathways.

The Hippo Pathway: Immunity and Cancer.

The Hippo pathway and cancer immunity: friend or foe?

TAZ enhances mammary cell proliferation in 3D culture through transcriptional regulation of IRS1.